Minimally Invasive Gynecological Surgery

6. Endometrial Polyps

Marit Lieng1, 2  


Department of Gynaecology, Oslo University Hospital, Oslo, Norway


Institute of Clinical Medician, University of Oslo, Oslo, Norway

Marit Lieng


6.1 Definition

6.2 Histological Features and Classification

6.3 Prevalence

6.4 Pathophysiology

6.5 Associated Factors

6.6 Symptoms and Clinical Consequences

6.7 Malignancy

6.8 Diagnosis

6.9 Treatment






Abnormal uterine bleeding


Body mass index


Contrast-enhanced ultrasonography


Growth factors


Gel installation sonography


Hormone therapy


Insulin-like growth factor


In vitro fertilization


Sex-hormone-binding globulin


Saline infusion sonography


Transcervical resection of endometrial polyps


Transvaginal ultrasonography

6.1 Definition

Endometrial polyps are sessile or pedunculated smooth-margined masses merging from the endometrium and protruding into the uterine cavity (Fig. 6.1). Endometrial polyps are usually benign and occur over a wide age range. They may be diagnosed in asymptomatic women, but occur more frequently in women suffering from AUB (Anastasiadis et al. 2000; Clevenger-Hoeft et al. 1999; Peterson and Novak 1956; Reslova et al. 1999). Endometrial polyps are usually solitary, but may be multiple (Mazur and Kurman 2005). They vary in size, ranging from a few millimetres to large lesions that can fill the uterine cavity or prolapse through the endocervical canal.


Fig. 6.1

Endometrial polyp as seen by hysteroscopy

6.2 Histological Features and Classification

The pathogenesis of endometrial polyps is not well understood, but they appear to originate from the endometrial basalis layer as focal overgrowths and consist of glands, stroma and thick-walled vessels (Mazur and Kurman 2005; Kurman 1982; Mutter et al. 2009). They may have a large flat base (sessile) or be attached to the endometrium by an elongated pedicle (pedunculated). Despite their diverse growth pattern, all endometrial polyps show typical histological features (Mazur and Kurman 2005; Kurman 1982; Mutter et al. 2009; Schlaen et al. 1988). In biopsy specimens, endometrial polyps typically present as larger, often polypoid shaped, tissue fragments with surface epithelium on three sides. The stroma of the polyp can be highly variable, but is often dense, and may include thick-walled vessels. The glands are irregular in shape and have a variable architecture.

Benign endometrial polyps can be classified, based on morphological features, into five morphological forms: proliferative/hyperplastic polyps, atrophic polyps, functional polyps, mixed endometrial–endocervical polyps, and adenomyomatous polyps (Mazur and Kurman 2005). The morphological patterns of benign endometrial polyps often overlap and have limited clinical significance for therapeutic decisions. Endometrial polyps are usually benign, but they may contain focal hyperplasia, focal complex hyperplasia, atypical hyperplasia, intraepithelial carcinoma or carcinoma (Peterson and Novak 1956; Mazur and Kurman 2005).

6.3 Prevalence

In textbooks of pathology, the prevalence of endometrial polyps is quoted to be approximately 25 % (Mazur and Kurman 2005; Kurman 1982; Mutter et al. 2009). The reported prevalence of endometrial polyps in women suffering from AUB varies between 10 and 40 % (Anastasiadis et al. 2000; Clevenger-Hoeft et al. 1999; Cohen 2004; Goldstein et al. 1997; Nagele et al. 1996a; van Bogaert 1988). The prevalence appears to increase by age during the reproductive years, but it is not clear whether it subsequently peaks or decreases after menopause (Anastasiadis et al. 2000; Clevenger-Hoeft et al. 1999; Peterson and Novak 1956; Reslova et al. 1999; van Bogaert 1988). Endometrial polyps are more common in women suffering from AUB, compared to women without such symptoms (Clevenger-Hoeft et al. 1999). Consequently, the large variation in reported prevalence of polyps may, among other factors, be explained by heterogeneous study populations in terms of age and eventual presence of symptoms. Furthermore, varying definitions and diagnostic methods, and difficulties in establishment of the histological diagnosis may contribute to the large variation in the reported prevalence of endometrial polyps (Mazur and Kurman 2005; van Bogaert 1988; Dreisler et al. 2009a).

The prevalence of endometrial polyps in asymptomatic women has been sparsely studied. In asymptomatic premenopausal women, the reported prevalence of endometrial polyps varies between 1 and 11 % (Clevenger-Hoeft et al. 1999; Dreisler et al. 2009a; Cooper et al. 1983; DeWaay et al. 2002). In asymptomatic women aged 45–50 years, the prevalence is reported to be 12 %, and in two studies evaluating asymptomatic postmenopausal women, the prevalence of endometrial polyps was found to be 12 and 17 % respectively (Dreisler et al. 2009a; Fay et al. 1999; Lieng et al. 2009).

6.4 Pathophysiology

Although endometrial polyps occur relatively often, the knowledge of the aetiology and pathogenesis of such polyps is limited. Endometrial polyps are believed to develop as a consequence of focal stromal and glandular overgrowth caused by prolonged oestrogen exposure (Schlaen et al. 1988; Lopes et al. 2007; Ryan et al. 2005; Sant’Ana de Almeida et al. 2004). The balance between mitotic activity and apoptosis is considered to regulate normal endometrial development during the menstrual cycle, and disturbances of these physiological processes have been proposed to occur in endometrial polyps (Stewart et al. 1999). Oestrogen and progesterone act, via their receptors, as modulators of proliferation and differentiation in the normal endometrium (Inceboz et al. 2006). Both oestrogen and progesterone receptors have been identified in the glandular epithelium of endometrial polyps in both post- and premenopausal women, but the receptor expression appears to be disorderly compared with normal endometrium (Lopes et al. 2007; Ryan et al. 2005; Mittal et al. 1996; McGurgan et al. 2006a).

Furthermore, demonstrations of increased levels of Ki61, a marker of cell proliferation, and Bcl-2, an inhibitor of apoptosis, indicate that loss of usual control mechanisms for growth may be of importance in development of endometrial polyps (Inceboz et al. 2006; McGurgan et al. 2006a; Maia et al. 2004a; Mertens et al. 2002; Taylor et al. 2003). This loss of proapoptotic mechanisms may be related to unopposed hyperestrogenism, because Bcl-2 expression increases in response to oestrogen (Mertens et al. 2002; Dahmoun et al. 1999). Oestrogen may consequently have a role in the development of endometrial polyps either by direct stimulation of localized proliferation, or by stimulation of proliferation via activation of Ki67 or inhibition of apoptosis via Bcl-2 (Inceboz et al. 2006). Available data also indicate that unopposed hyperestrogenism can lead to an abnormal increase of certain growth factors (GF) and growth factor receptors within the endometrium, which may stimulate endometrial polyp growth (Maia et al. 2001). Cytogenic abnormalities following altered gene expressions have been identified in endometrial polyp tissue (Bol et al. 1996; Nogueira et al. 2006; Vanni et al. 1993). However, any effect of these findings in the development of endometrial polyps is not known, and the studies are small and need to be confirmed in future studies including a larger number of endometrial polyps.

6.5 Associated Factors

Increasing age appears to be the best-documented risk indicator for endometrial polyps (Anastasiadis et al. 2000; Clevenger-Hoeft et al. 1999; Reslova et al. 1999; Nagele et al. 1996a; van Bogaert 1988; Dreisler et al. 2009a; Nappi et al. 2009; Vilodre et al. 1997). Some authors report that the peak prevalence of endometrial polyps occurs during the last decade of the fertile years (Clevenger-Hoeft et al. 1999; van Bogaert 1988), while others report menopause as a risk indicator for the development of endometrial polyps (Anastasiadis et al. 2000; Reslova et al. 1999; Nagele et al. 1996a; Dreisler et al. 2009a; Vilodre et al. 1997). In two reports using age-adjusted regression models, menopause was not found to be associated with a higher prevalence of endometrial polyps (Nappi et al. 2009; Dreisler et al. 2009b).

Endometrial polyps have been reported to occur more often in women with obesity, hypertension, fibroids, endometriosis, or cervical polyps (Clevenger-Hoeft et al. 1999; Peterson and Novak 1956; Reslova et al. 1999; Vilodre et al. 1997; Dreisler et al. 2009b; Onalan et al. 2009; Oguz et al. 2005; Coeman et al. 1993; Kim et al. 2003; McBean et al. 1996). The results of two prospective trials including 245 and 375 women, respectively, indicate an association of obesity and endometrial polyps (Reslova et al. 1999; Oguz et al. 2005). This association was also reported in a retrospective study including 230 women undergoing in vitro fertilization (IVF), where BMI ≥ 30 kg/m2 was found to be an independent risk factor for the development of endometrial polyps (Onalan et al. 2009). Obesity is characterized by decreased sex-hormone-binding globulin (SHBG) levels, increased aromatization of androgens to oestrogens in adipose tissue and high levels of unopposed oestrogen in the circulation (Onalan et al. 2009). This relative hyperestrogenism may explain the development of endometrial polyps in obese women. Both obesity and hypertension are conditions related to an abnormal increase in serum and endometrial tissue of growth factors such as free insulin-like GF (IGF)-1, which might be of importance for the development of endometrial polyps (Maia et al. 2001). But reports regarding obesity as an associated factor with endometrial polyps are not consistent.

Similarly, a relationship between hypertension and development of endometrial polyps has been suggested (Reslova et al. 1999). However, no association between hypertension and development of endometrial polyps was found in the two studies using logistic regression models for adjustments for age and overweight (Nappi et al. 2009; Dreisler et al. 2009b).

Endometrial polyps are furthermore reported to occur more often in women with fibroids, cervical polyps, and endometriosis (Clevenger-Hoeft et al. 1999; Peterson and Novak 1956; Vilodre et al. 1997; Coeman et al. 1993; Kim et al. 2003; McBean et al. 1996). Most of these studies are retrospective and include relatively few patients. The pathogeneses of any associations between endometrial polyps and fibroids, cervical polyps and endometriosis appears not to be considered, but it might be related to oestrogen influence.

Tibolon appears to increase the risk of endometrial polyp development (Perez-Medina et al. 2003). Data regarding an eventual relationship between hormone therapy (HT) and endometrial polyps are contradicting, as some studies report higher prevalence of endometrial polyps in women using HT (Dreisler et al. 2009b; Maia et al. 1996), whereas others do not (Akkad et al. 1995; Bakour et al. 2002; Elliott et al. 2003; Orvieto et al. 1999). In an experimental study, Maja et al. found that HT may cause endometrial polyp involution by decreasing proliferation and stimulating apoptosis (Maia et al. 2004b). In accordance with this finding, Perrone et al. reported a lower prevalence of endometrial polyps in women using HT compared to a control group (Perrone et al. 2002). Endometrial polyp formation has been reported to be dependent on the type and dosage of HT (Oguz et al. 2005; Iatrakis et al. 2006). Furthermore, a progestogen with high antipestrogenic activity, as well as use of oral contraceptive pills may have a protective effect on the development of endometrial polyps (Dreisler et al. 2009b; Oguz et al. 2005). An eventual protective effect of levonorgesterel-releasing intrauterine devices on the development of endometrial polyps seems not to have been evaluated.

Tamoxifen has in previous studies shown a consistent relationship with the development of endometrial polyps (Reslova et al. 1999; Cohen 2004; Bakour et al. 2002; Chalas et al. 2005; De Muylder et al. 1991; Kedar et al. 1994). Tamoxifen appears to have a significant effect on hormone receptor expression and markers of apoptosis in endometrial polyps, which support the hypothesis stating that tamoxifen promotes polyp growth by inhibiting apoptosis (McGurgan et al. 2006b). This hypothesis is furthermore substantiated by the report by Gardener et al., indicating that the levonorgestrel-releasing intrauterine system has a protective action against the uterine effects of tamoxifen (Gardner et al. 2000).

6.6 Symptoms and Clinical Consequences

The majority of endometrial polyps are probably asymptomatic (Ryan et al. 2005). Most symptomatic women with endometrial polyps present with different forms of AUB (intermenstrual bleeding, menorrhagia, metrorrhagia, postmenopausal bleeding), and endometrial polyps are found in about 10–40 % of women suffering from such symptoms (Anastasiadis et al. 2000; Clevenger-Hoeft et al. 1999; Goldstein et al. 1997; van Bogaert 1988). It is not known why endometrial polyps may cause AUB, but it is believed that abbreviations in hormone receptor expression within polyps may lead to an abnormal response to the hormonal environment, causing tissue breakdown and bleeding (Ryan et al. 2005). Although different forms of AUB constitute the dominating symptom in women with endometrial polyps, women with such polyps also may present with dysmenorrhoea, vaginal discharge or endometritis caused by extension of large polyps into the endocervix by dilatation of the internal cervical os (Mazur and Kurman 2005; Ryan et al. 2005).

In a large prospective trial evaluating 1,000 infertile women scheduled for IVF, the prevalence of endometrial polyps was found to be 32 % (Hinckley and Milki 2004). The high prevalence of endometrial polyps in infertile women suggests a causative relationship between the presence of endometrial polyps and infertility (Hinckley and Milki 2004; Frydman et al. 1987; Seinera et al. 1988; Syrop and Sahakian 1992). However, a causal relationship between endometrial polyps and infertility appears to have been confirmed in only one prospective randomized trial (Perez-Medina et al. 2005). In this trial allocating women with endometrial polyps to hysteroscopic polypectomy or diagnostic hysteroscopy prior to intrauterine insemination, women in the resection group had a significant higher chance of becoming pregnant. The results of a retrospective trial also indicate that hysteroscopic polypectomy may enhance fertility in women with endometrial polyps compared with infertile women with normal cavity (Varasteh et al. 1999). On the other hand, endometrial polyps did not appear to impair implantation outcome during IVF in two other retrospective studies (Isikoglu et al. 2006; Lass et al. 1999). A trend towards increased early pregnancy loss among women with endometrial polyps was reported in one of these studies (Lass et al. 1999).

The knowledge regarding the natural history and clinical consequences of endometrial polyps without treatment is limited. Only two studies have prospectively followed a cohort of women with endometrial polyps to investigate the spontaneous polyp regression rate (DeWaay et al. 2002; Lieng et al. 2009). The follow up-period was 2.5 and 1 year, and the spontaneous regression rate was reported to be 0.6 and 0.3, respectively. In both studies, polyps that regressed tended to be smaller compared to polyps that persisted during the follow-up period. Because of small study samples, these results must be interpreted with care.

6.7 Malignancy

Although the knowledge regarding the malignant potential of endometrial polyps is limited, polyps are believed to be a risk indicator for the development of premalignant and malignant tissue changes (Savelli et al. 2003). Both atypical hyperplasia and endometrial carcinoma may originate from endometrial polyps. The most common subtypes of endometrial carcinoma in malignant endometrial polyps appear to be endometroid carcinoma and serous papillary carcinoma (Farrell et al. 2005; Giordano et al. 2007). Most commonly, endometrial carcinoma arising in endometrial polyps is an early carcinoma with good prognosis, except for papillary serous carcinoma, which can be associated with omental involvement, despite low stage of malignant development in the uterus (Giordano et al. 2007).

There appears to be only one controlled study evaluating an association of endometrial polyps with premalignant and malignant pathology (Bakour et al. 2000). In this prospective study including 248 women with AUB, hyperplasia was found to be more frequent among women with endometrial polyps compared to women without polyps (7/62 vs 8/186), but no such differences between the two study groups were found for malignancy (2/62 vs 6/162).

The results of numerous previous case series evaluating histological diagnosis of resected polyps indicate that atypia and malignancy occur within 0.3–23.8 % and 0.8–3.2 % of endometrial polyps respectively (Anastasiadis et al. 2000; Orvieto et al. 1999; Savelli et al. 2003; Bakour et al. 2000; Antunes et al. 2007; Ben-Arie et al. 2004; Ferrazzi et al. 2009; Machtinger et al. 2005; Papadia et al. 2007; Shushan et al. 2004; Lieng et al. 2007). Most authors seem to agree that the prevalence of malignancy in endometrial polyps varies by age and menopausal status. According to the available evidence, the risk of malignancy in premenopausal women appears to be low. Gynaecological symptoms have also been identified as a possible risk indicator of malignancy within endometrial polyps (Antunes et al. 2007; Ferrazzi et al. 2009; Shushan et al. 2004; Lieng et al. 2007). However, previous reports evaluating the prevalence of malignancy within endometrial polyps in symptomatic as well as asymptomatic women are not consistent. Polyp size has been reported to be a risk indicator for malignant endometrial polyps (Ben-Arie et al. 2004; Ferrazzi et al. 2009), among others by the authors of a large retrospective multicenter study including both asymptomatic and symptomatic postmenopausal women with endometrial polyps (Ferrazzi et al. 2009).

Although the reports are not consistent, other known risk factors for endometrial carcinoma, such as obesity, diabetes mellitus and hypertension have also been reported to increase the risk of malignancy within endometrial polyps (Anastasiadis et al. 2000; Savelli et al. 2003; Bernstein et al. 1999). Furthermore, tamoxifen appears to increase the risk of atypical hyperplasia and malignancy in endometrial polyps (Cohen 2004; Kedar et al. 1994; Bernstein et al. 1999).

The reported prevalence of atypia and malignancy within endometrial polyps consequently varies according to the population studied, and the relatively large variation in reported prevalence probably reflects that the populations in the different studies are heterogeneous in terms of age and symptoms. Furthermore, the definition of a malignant endometrial polyp varies in previous publications, as some define the malignant tissue changes as a malignant polyp only if the stalk and surrounding endometrium are free of cancer, while others do not require this as an assumption (Ferrazzi et al. 2009). Varying definitions of the histopathological diagnosis may consequently contribute to the relatively large variation of reported prevalence of malignancy within endometrial polyps.

6.8 Diagnosis

Previously, endometrial polyps were diagnosed by histological examination of specimens retrieved by curettage and hysterectomy from women suffering from AUB. The technical advancement of ultrasound, including high-frequency vaginal transducers, has enabled an improved view of the endometrium. This has led to a new era in the diagnostics of focal intracavitary processes.

In women with postmenopausal bleeding, measurements of the bilayer endometrial thickness have been documented effective for exclusion of malignancy, but it appear to have poor discriminative ability for detecting or excluding endometrial polyps (Gupta et al. 2002; Timmermans et al. 2008). In premenopausal women with AUB, diverging results have been reported regarding the diagnostic value of endometrial thickness measurements for the detection of focal intracavitary processes, including endometrial polyps (Goldstein et al. 1997; Dijkhuizen et al. 1996; Dueholm et al. 2001; Schwarzler et al. 1998; Vercellini et al. 1997). Despite the widespread use of TVUS during general gynaecological examinations, the diagnostic value of endometrial thickness measurements in asymptomatic women has been sparsely investigated. In a study including 375 asymptomatic women aged 20–74 years, measurement of endometrial thickness by TVUS was found of little use as a diagnostic tool for the detection of focal intracavitary processes, but more efficacious in excluding focal intrauterine pathology, especially in postmenopausal women (Dreisler et al. 2009c). Sonographic examination using artificial uterine cavity distension, such as saline infusion sonography (SIS) or gel installation sonography (GIS), appears to improve the diagnostic accuracy of TVUS in case of abnormal or inclusive findings and has a high sensitivity and specificity for the detection of intrauterine pathology (Fig. 6.2) (Anastasiadis et al. 2000; Syrop and Sahakian 1992; van Roessel et al. 1987; Parsons and Lense 1993; de Kroon et al. 2003; Jansen et al. 2006; Guven et al. 2004). Hysteroscopy and SIS appear to be equivalent diagnostic tools for the detection of endometrial polyps and intrauterine myomas in the evaluation of both premenopausal and postmenopausal women with AUB (van Roessel et al. 1987; Parsons and Lense 1993; Dijkhuizen et al. 2000; Pasqualotto et al. 2000; Widrich et al. 1996).


Fig. 6.2

Endometrial polyp protruding into the uterine cavity as seen during saline infusion sonography

Demonstration of the feeding vessel of the endometrial polyp by transvaginal colour or power Doppler examination may be of diagnostic importance in discrimination of endometrial lesions with different vascular patterns, such as polyps and fibroids (Fig. 6.3) (Krampl et al. 2001; Exalto et al. 2007; Fleischer and Shappell 2003).


Fig. 6.3

Power Doppler sonogram showing the feeding vessel characteristic of endometrial polyps

Neither ultrasonography nor hysteroscopic features have been proved successful in distinguishing benign from malignant endometrial polyps (Shushan et al. 2004; Jakab et al. 2005; Timmerman et al. 2003; Bettocchi et al. 2004a). Previous studies suggest that evaluation of tissue vascularization by power or colour flow Doppler imaging may be useful in the prediction of malignant endometrial changes, due to the increased blood flow in malignant lesions (Epstein et al. 2001; Fernandez-Parra et al. 2006). Low Doppler resistance of the feeding vessel of endometrial polyps has been reported to be predictive of atypia and malignancy (Aleem et al. 1995; Lieng et al. 2008).

Techniques such as three-dimensional (3D) ultrasonography, power Doppler angiography and contrast-enhanced ultrasonography (CEUS) appear to improve the quality and accuracy of Doppler examinations and provide a relatively new and more comprehensive assessment of tumour vascularization, compared to the two-dimensional colour or power Doppler. Such new techniques may prove to be useful for prediction of atypia or malignancy in intrauterine lesions such as endometrial polyps, in the future. However, this needs further investigation.

Accordingly, histopathology is still required to exclude atypia and malignancy within endometrial polyps. The diagnostic accuracy of blind endometrial sampling obtained by an endometrial suction curette is low in the presence of endometrial polyps (Maia et al. 1996; Carter et al. 1994; Perez-Medina et al. 2002; Merce et al. 2007; Raine-Fenning et al. 2003). A device for SIS-based guided biopsies has been developed, but the diagnostic accuracy of this method has not been evaluated in comparative studies (Sidhu et al. 2006). As curettage misses the endometrial polyps in many cases, hysteroscopy combined with histopathological examination of retrieved specimens is still the gold standard for exclusion of malignancy in endometrial polyps (Bokor et al. 2001; Testa et al. 2005).

6.9 Treatment

Treatment of endometrial polyps is performed in order to exclude premalignant and/or malignant tissue changes, relieve symptoms (AUB) or improve fertility outcomes in infertile women.

Endometrial polyps were previously treated by curettage or hysterectomy (Elpek et al. 1998). The results of previous studies indicate that about 10 % of polyps remain in situ after curettage (Hann et al. 2003; Svirsky et al. 2008). More recently, Bonvolonta et al. found, by control hysteroscopy after curettage, that the polyp was fully removed in only 2 out of 25 women (Tanriverdi et al. 2004). As opposed to curettage, hysteroscopy allows, under visional control, the complete removal of the polyp. Due to the considerable limitation of curettage, transcervical (hysteroscopic) resection of endometrial polyps (TCRP) is today regarded as the optimal treatment of endometrial polyps (de Kroon and Jansen 2006; Smith and Schulman 1985; Gimpelson and Rappold 1988). The procedure is most often performed in an inpatient setting under general anaesthesia (Chavez et al. 2002). However, it appears that at least smaller endometrial polyps may be resected in an office setting without significant discomfort to the women (Englund et al. 1957).

TCRP carries a relative low risk of complications (Nagele et al. 1996a; de Kroon and Jansen 2006; Word et al. 1958; Bonavolonta et al. 1994). Complications during hysteroscopic polyp resection are most often related to fluid overload or hyponatremia, or are encountered during cervical dilatation (Bonavolonta et al. 1994; Cravello et al. 2000). Complications during cervical dilatation occur mainly in nulliparous or postmenopausal women and include cervical tears, creation of false passages and uterine perforation. However, the risk of complications during dilatation may be reduced by ensuring adequate preoperative cervical priming (Bonavolonta et al. 1994; Gebauer et al. 2001).

Despite the widespread use of TCRP, the efficacy of the procedure has been scarcely evaluated (Preutthipan and Herabutya 2005). The results of previous studies indicate that the procedure is effective in terms of relieving symptoms (de Kroon and Jansen 2006; Gimpelson and Rappold 1988; Clark et al. 2002). The effect appears to be better in women suffering from intermenstrual bleedings/spotting compared to women with heavy bleeding (Lieng et al. 2010a). However, the risk of persistence or recurrence of AUB in premenopausal women after treatment appears to be relatively high (Bettocchi et al. 2004b; Propst et al. 2000).

Hysterectomy is a major procedure and is nowadays considered too comprehensive for the treatment of isolated benign intrauterine lesions. Hysterectomy is consequently confined to polyps with premalignant or malignant changes. If histological evaluation following TCRP reveals atypical complex hyperplasia or carcinoma in endometrial polyps, a subsequent hysterectomy should be performed, even if the malignant or premalignant tissue changes appear confined to the polyp in the initial sampling (Bradley 2002).

The large range of prevalence of premalignant and/or malignant tissue changes within endometrial polyps as well as the scarcity of evidence supporting transcervical resection of polyps in order to relieve symptoms or improve fertility outcomes limits the strength of clinical recommendations. Although TCRP is a relatively safe procedure with a low risk of major complications, it should be performed on indication in order to reduce both surgical-related morbidity and costs. An individual approach is mandatory in the management of women with endometrial polyps and the woman’s opinion regarding treatment or not also has to be taken into account. An expectant approach may be reasonable in asymptomatic premenopausal women, as the malignant potential appears to be low. In infertile women, resection of endometrial polyps appears to improve fertility outcome. Premenopausal women with endometrial polyps suffering from intermenstrual bleedings seem to have a favourable outcome of TCRP in terms of symptom relief. However, removal of endometrial polyps in women suffering from heavy bleeding appears to be less effective, and appropriate additional treatment such as the levonorgesterel intrauterine device or a concomitant endometrial resection in order to reduce periodic blood loss should be considered. In asymptomatic postmenopausal women, treatment needs to be individualised based on polyp size, malignancy risk indicators, general condition as well as women’s concerns regarding malignancy. If the woman wants to have malignancy ruled out by histopathological examination, if the polyp is large or if other risk indicators for malignancy such as use of tamoxifen or obesity are present, TCRP should be recommended. Symptomatic postmenopausal women carry the highest risk of malignancy and should consequently have the polyp resected for curative as well as diagnostic reasons (Lieng et al. 2010b; Abbott et al. 2012).


Abbott J, Jansen FW, Lieng M, Tulandi T (2012) AAGL practice report: practice guidelines for the diagnosis and management of endometrial polyps. J Minim Invasive Gynecol 19:3–10

Akkad AA, Habiba MA, Ismail N, Abrams K, Al-Azzawi F (1995) Abnormal uterine bleeding on hormone replacement: the importance of intrauterine structural abnormalities. Obstet Gynecol 86:330–334PubMed

Aleem F, Predanic M, Calame R, Moukhtar M, Pennisi J (1995) Transvaginal color and pulsed Doppler sonography of the endometrium: a possible role in reducing the number of dilatation and curettage procedures. J Ultrasound Med 14:139–145PubMed

Anastasiadis PG, Koutlaki NG, Skaphida PG, Galazios GC, Tsikouras PN, Liberis VA (2000) Endometrial polyps: prevalence, detection, and malignant potential in women with abnormal uterine bleeding. Eur J Gynaecol Oncol 21:180–183PubMed

Antunes A Jr, Costa-Paiva L, Arthuso M, Costa JV, Pinto-Neto AM (2007) Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy. Maturitas 57:415–421PubMed

Bakour SH, Khan KS, Gupta JK (2000) The risk of premalignant and malignant pathology in endometrial polyps. Acta Obstet Gynecol Scand 79:317–320PubMed

Bakour SH, Gupta JK, Khan KS (2002) Risk factors associated with endometrial polyps in abnormal uterine bleeding. Int J Gynaecol Obstet 76:165–168PubMed

Ben-Arie A, Goldchmit C, Laviv Y et al (2004) The malignant potential of endometrial polyps. Eur J Obstet Gynecol Reprod Biol 115:206–210PubMed

Bernstein L, Deapen D, Cerhan JR et al (1999) Tamoxifen therapy for breast cancer and endometrial cancer risk. J Natl Cancer Inst 91:1654–1662PubMed

Bettocchi S, Nappi L, Ceci O, Selvaggi L (2004a) Office hysteroscopy. Obstet Gynecol Clin North Am 31:641–654PubMed

Bettocchi S, Ceci O, Nappi L, Di VR, Masciopinto V, Pansini V et al (2004b) Operative office hysteroscopy without anesthesia: analysis of 4863 cases performed with mechanical instruments. J Am Assoc Gynecol Laparosc 11:59–61PubMed

Bokor D, Chambers JB, Rees PJ, Mant TG, Luzzani F, Spinazzi A (2001) Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease. Invest Radiol 36:104–109PubMed

Bol S, Wanschura S, Thode B et al (1996) An endometrial polyp with a rearrangement of HMGI-C underlying a complex cytogenetic rearrangement involving chromosomes 2 and 12. Cancer Genet Cytogenet 90:88–90PubMed

Bonavolonta G, Rossetti A, Cannella PL, Campo S, Garcea N (1994) Curettage vs. hysteroscopic resection. Minerva Ginecol 46:1–3PubMed

Bradley LD (2002) Complications in hysteroscopy: prevention, treatment and legal risk. Curr Opin Obstet Gynecol 14:409–415PubMed

Carter J, Saltzman A, Hartenbach E, Fowler J, Carson L, Twiggs LB (1994) Flow characteristics in benign and malignant gynecologic tumors using transvaginal color flow Doppler. Obstet Gynecol 83:125–130PubMed

Chalas E, Costantino JP, Wickerham DL, Wolmark N, Lewis GC, Bergman C et al (2005) Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial. Am J Obstet Gynecol 192:1230–1237PubMed

Chavez NF, Garner EO, Khan W et al (2002) Does the introduction of new technology change population demographics? Minimally invasive technologies and endometrial polyps. Gynecol Obstet Invest 54:217–220PubMed

Clark TJ, Khan KS, Gupta JK (2002) Current practice for the treatment of benign intrauterine polyps: a national questionnaire survey of consultant gynaecologists in UK. Eur J Obstet Gynecol Reprod Biol 103:65–67PubMed

Clevenger-Hoeft M, Syrop CH, Stovall DW, Van Voorhis BJ (1999) Sonohysterography in premenopausal women with and without abnormal bleeding. Obstet Gynecol 94:516–520PubMed

Coeman D, Van BY, Vanderick G, De Muylder X, De Muylder E, Campo R (1993) Hysteroscopic findings in patients with a cervical polyp. Am J Obstet Gynecol 169:1563–1565PubMed

Cohen I (2004) Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecol Oncol 94:256–266PubMed

Cooper JM, Houck RM, Rigberg HS (1983) The incidence of intrauterine abnormalities found at hysteroscopy in patients undergoing elective hysteroscopic sterilization. J Reprod Med 28:659–661PubMed

Cravello L, Stolla V, Bretelle F, Roger V, Blanc B (2000) Hysteroscopic resection of endometrial polyps: a study of 195 cases. Eur J Obstet Gynecol Reprod Biol 93:131–134PubMed

Dahmoun M, Boman K, Cajander S, Westin P, Backstrom T (1999) Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of the secretory phase. J Clin Endocrinol Metab 84:1737–1743PubMed

de Kroon CD, Jansen FW (2006) Saline infusion sonography in women with abnormal uterine bleeding: an update of recent findings. Curr Opin Obstet Gynecol 18:653–657PubMed

de Kroon CD, de Bock GH, Dieben SW, Jansen FW (2003) Saline contrast hysterosonography in abnormal uterine bleeding: a systematic review and meta-analysis. Br J Obstet Gynaecol 110:938–947

De Muylder X, Neven P, De Somer M, Van Belle Y, Vanderick G, De Muylder E (1991) Endometrial lesions in patients undergoing tamoxifen therapy. Int J Gynaecol Obstet 36:127–130PubMed

DeWaay DJ, Syrop CH, Nygaard IE, Davis WA, Van Voorhis BJ (2002) Natural history of uterine polyps and leiomyomata. Obstet Gynecol 100:3–7PubMed

Dijkhuizen FP, Brolmann HA, Potters AE, Bongers MY, Heinz AP (1996) The accuracy of transvaginal ultrasonography in the diagnosis of endometrial abnormalities. Obstet Gynecol 87:345–349PubMed

Dijkhuizen FP, De Vries LD, Mol BW et al (2000) Comparison of transvaginal ultrasonography and saline infusion sonography for the detection of intracavitary abnormalities in premenopausal women. Ultrasound Obstet Gynecol 15:372–376PubMed

Dreisler E, Stampe SS, Ibsen PH, Lose G (2009a) Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20–74 years. Ultrasound Obstet Gynecol 33:102–108PubMed

Dreisler E, Sorensen SS, Lose G (2009b) Endometrial polyps and associated factors in Danish women aged 36–74 years. Am J Obstet Gynecol 200:147.e1–6

Dreisler E, Sorensen SS, Ibsen PH, Lose G (2009c) Value of endometrial thickness measurement for diagnosing focal intrauterine pathology in women without abnormal uterine bleeding. Ultrasound Obstet Gynecol 33:344–348PubMed

Dueholm M, Jensen ML, Laursen H, Kracht P (2001) Can the endometrial thickness as measured by trans-vaginal sonography be used to exclude polyps or hyperplasia in pre-menopausal patients with abnormal uterine bleeding? Acta Obstet Gynecol Scand 80:645–651PubMed

Elliott J, Connor ME, Lashen H (2003) The value of outpatient hysteroscopy in diagnosing endometrial pathology in postmenopausal women with and without hormone replacement therapy. Acta Obstet Gynecol Scand 82:1112–1119PubMed

Elpek G, Uner M, Elpek GO, Sedele M, Karaveli S (1998) The diagnostic accuracy of the Pipelle endometrial sampler in the presence of endometrial polyps. J Obstet Gynaecol 18:274–275PubMed

Englund S, Ingelman-Sundberg A, Westin B (1957) Hysteroscopy in diagnosis and treatment of uterine bleeding. Gynaecologia 143:217–222PubMed

Epstein E, Ramirez A, Skoog L, Valentin L (2001) Transvaginal sonography, saline contrast sonohysterography and hysteroscopy for the investigation of women with postmenopausal bleeding and endometrium >5 mm. Ultrasound Obstet Gynecol 18:157–162PubMed

Exalto N, Stappers C, van Raamsdonk LA, Emanuel MH (2007) Gel instillation sonohysterography: first experience with a new technique. Fertil Steril 87:152–155PubMed

Farrell R, Scurry J, Otton G, Hacker NF (2005) Clinicopathologic review of malignant polyps in stage 1A carcinoma of the endometrium. Gynecol Oncol 98:254–262PubMed

Fay TN, Khanem N, Hosking D (1999) Out-patient hysteroscopy in asymptomatic postmenopausal women. Climacteric 2:263–267PubMed

Fernandez-Parra J, Rodriguez OA, Lopez CS, Parrilla FF, Montoya VF (2006) Hysteroscopic evaluation of endometrial polyps. Int J Gynaecol Obstet 95:144–148PubMed

Ferrazzi E, Zupi E, Leone FP et al (2009) How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study. Am J Obstet Gynecol 200:235–236PubMed

Fleischer AC, Shappell HW (2003) Color Doppler sonohysterography of endometrial polyps and submucosal fibroids. J Ultrasound Med 22:601–604PubMed

Frydman R, Eibschitz I, Fernandez H, Hamou J (1987) Uterine evaluation by microhysteroscopy in IVF candidates. Hum Reprod 2:481–485PubMed

Gardner FJ, Konje JC, Abrams KR et al (2000) Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial. Lancet 356:1711–1717PubMed

Gebauer G, Hafner A, Siebzehnrubl E, Lang N (2001) Role of hysteroscopy in detection and extraction of endometrial polyps: results of a prospective study. Am J Obstet Gynecol 184:59–63PubMed

Gimpelson RJ, Rappold HO (1988) A comparative study between panoramic hysteroscopy with directed biopsies and dilatation and curettage. A review of 276 cases. Am J Obstet Gynecol 158:489–492PubMed

Giordano G, Gnetti L, Merisio C, Melpignano M (2007) Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps. Maturitas 56:190–197PubMed

Goldstein SR, Zeltser I, Horan CK, Snyder JR, Schwartz LB (1997) Ultrasonography-based triage for perimenopausal patients with abnormal uterine bleeding. Am J Obstet Gynecol 177:102–108PubMed

Gupta JK, Chien PF, Voit D, Clark TJ, Khan KS (2002) Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand 81:799–816PubMed

Guven MA, Bese T, Demirkiran F (2004) Comparison of hydrosonography and transvaginal ultrasonography in the detection of intracavitary pathologies in women with abnormal uterine bleeding. Int J Gynecol Cancer 14:57–63PubMed

Hann LE, Kim CM, Gonen M, Barakat R, Choi PH, Bach AM (2003) Sonohysterography compared with endometrial biopsy for evaluation of the endometrium in tamoxifen-treated women. J Ultrasound Med 22:1173–1179PubMed

Hinckley MD, Milki AA (2004) 1000 office-based hysteroscopies prior to in vitro fertilization: feasibility and findings. JSLS 8:103–107PubMedCentralPubMed

Iatrakis G, Zervoudis S, Antoniou E, Tsionis C, Pavlou A, Kourounis G et al (2006) Is dosage of hormone replacement therapy related with endometrial polyp formation? Eur J Gynaecol Oncol 27:393–394PubMed

Inceboz US, Nese N, Uyar Y et al (2006) Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps. Gynecol Obstet Invest 61:24–28PubMed

Isikoglu M, Berkkanoglu M, Senturk Z, Coetzee K, Ozgur K (2006) Endometrial polyps smaller than 1.5 cm do not affect ICSI outcome. Reprod Biomed Online 12:199–204PubMed

Jakab A, Ovari L, Juhasz B, Birinyi L, Bacsko G, Toth Z (2005) Detection of feeding artery improves the ultrasound diagnosis of endometrial polyps in asymptomatic patients. Eur J Obstet Gynecol Reprod Biol 119:103–107PubMed

Jansen FW, de Kroon CD, van Dongen H, Grooters C, Louwe L, Trimbos-Kemper T (2006) Diagnostic hysteroscopy and saline infusion sonography: prediction of intrauterine polyps and myomas. J Minim Invasive Gynecol 13:320–324PubMed

Kedar RP, Bourne TH, Powles TJ, Collins WP, Ashley SE, Cosgrove DO et al (1994) Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343:1318–1321PubMed

Kim MR, Kim YA, Jo MY, Hwang KJ, Ryu HS (2003) High frequency of endometrial polyps in endometriosis. J Am Assoc Gynecol Laparosc 10:46–48PubMed

Krampl E, Bourne T, Hurlen-Solbakken H, Istre O (2001) Transvaginal ultrasonography sonohysterography and operative hysteroscopy for the evaluation of abnormal uterine bleeding. Acta Obstet Gynecol Scand 80:616–622PubMed

Kurman RJ (1982) Benign diseases of the endometrium. In: Blaustein A (ed) Pathology of the female genital tract, 2nd edn. Springer, New York/Heidelberg/Berlin, pp 279–310

Lass A, Williams G, Abusheikha N, Brinsden P (1999) The effect of endometrial polyps on outcomes of in vitro fertilization (IVF) cycles. J Assist Reprod Genet 16:410–415PubMedCentralPubMed

Lieng M, Qvigstad E, Sandvik L, Jørgensen H, Langebrekke A, Istre O (2007) Hysteroscopic resection of symptomatic and asymptomatic endometrial polyps. J Minim Invasive Gynecol 14(2):189–194PubMed

Lieng M, Qvigstad E, Dahl GF, Istre O (2008) Flow differences between endometrial polyps and endometrial cancer: a prospective study using contrasted transvaginal color flow Doppler and three-dimensional power Doppler. Ultrasound Obstet Gynecol 32:935–940PubMed

Lieng M, Istre O, Sandvik L, Qvigstad E (2009) Prevalence, 1-year regression rate, and clinical significance of asymptomatic endometrial polyps: a cross-sectional study. J Minim Invasive Gynecol 16(4):465–471PubMed

Lieng M, Istre O, Sandvik L, Engh V, Qvigstad E (2010a) Clinical effectiveness of transcervical polyp resection in women with endometrial polyps: a randomised controlled trial. J Minim Invasive Gynecol 17:351–357PubMed

Lieng M, Istre O, Qvigstad E (2010b) Treatment of endometrial polyps A systematic review. Acta Obstet Gynecol Scand 89:992–1002PubMed

Lopes RG, Baracat EC, de Albuquerque Neto LC et al (2007) Analysis of estrogen- and progesterone-receptor expression in endometrial polyps. J Minim Invasive Gynecol 14:300–303PubMed

Machtinger R, Korach J, Padoa A et al (2005) Transvaginal ultrasound and diagnostic hysteroscopy as a predictor of endometrial polyps: risk factors for premalignancy and malignancy. Int J Gynecol Cancer 15:325–328PubMed

Maia H Jr, Barbosa IC, Marques D, Calmon LC, Ladipo OA, Coutinho EM (1996) Hysteroscopy and transvaginal sonography in menopausal women receiving hormone replacement therapy. J Am Assoc Gynecol Laparosc 4:13–18PubMed

Maia H, Maltez A, Athayde C, Coutinho EM (2001) Proliferation profile of endometrial polyps in post-menopausal women. Maturitas 40:273–281PubMed

Maia H Jr, Maltez A, Studart E, Athayde C, Coutinho EM (2004a) Ki-67, Bcl-2 and p53 expression in endometrial polyps and in the normal endometrium during the menstrual cycle. BJOG 111:1242–1247PubMed

Maia H Jr, Maltez A, Studard E, Athayde C, Coutinho EM (2004b) Effect of previous hormone replacement therapy on endometrial polyps during menopause. Gynecol Endocrinol 18:299–304PubMed

Mazur MT, Kurman RJ (2005) Polyps. In: Mazur MT, Kurman RJ (eds) Diagnosis of endometrial biopsies and curettings. A practical approach, 2nd edn. Springer Science and Business Media Inc., New York, pp 163–177

McBean JH, Gibson M, Brumsted JR (1996) The association of intrauterine filling defects on hysterosalpingogram with endometriosis. Fertil Steril 66:522–526PubMed

McGurgan P, Taylor LJ, Duffy SR, O’Donovan PJ (2006a) Are endometrial polyps from premenopausal women similar to post-menopausal women? An immunohistochemical comparison of endometrial polyps from pre- and post-menopausal women. Maturitas 54:277–284PubMed

McGurgan P, Taylor LJ, Duffy SR, O’Donovan PJ (2006b) Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen. Maturitas 54:252–259PubMed

Merce LT, Alcazar JL, Lopez C, Iglesias E et al (2007) Clinical usefulness of 3-dimensional sonography and power Doppler angiography for diagnosis of endometrial carcinoma. J Ultrasound Med 26:1279–1287PubMed

Mertens HJ, Heineman MJ, Evers JL (2002) The expression of apoptosis-related proteins Bcl-2 and Ki67 in endometrium of ovulatory menstrual cycles. Gynecol Obstet Invest 53:224–230PubMed

Mittal K, Schwartz L, Goswami S, Demopoulos R (1996) Estrogen and progesterone receptor expression in endometrial polyps. Int J Gynecol Pathol 15:345–348PubMed

Mutter GL, Nucci MR, Robboy SJ (2009) Endometritis, metaplasias, polyps and miscellaneous changes. In: Robboy SJ, Mutter GL, Prat J, Bentley RC, Russell P, Anderson MC (eds) Robboy’s pathology of the female reproductive tract, 2nd edn. Churchill Livingstone Elsevier, Edinburgh, pp 343–366

Nappi L, Indraccolo U, Di Spiezio SA, Gentile G, Palombino K, Castaldi MA et al (2009) Are diabetes, hypertension, and obesity independent risk factors for endometrial polyps? J Minim Invasive Gynecol 16:157–162PubMed

Nogueira AA, Sant’Ana de Almeida EC, Poli Neto OB, Zambelli Ramalho LN, Rosa e Silva JC, Candido dos Reis FJ (2006) Immunohistochemical expression of p63 in endometrial polyps: evidence that a basal cell immunophenotype is maintained. Menopause 13:826–830PubMed

Oguz S, Sargin A, Kelekci S, Aytan H, Tapisiz OL, Mollamahmutoglu L (2005) The role of hormone replacement therapy in endometrial polyp formation. Maturitas 50:231–236PubMed

Onalan R, Onalan G, Tonguc E, Ozdener T, Dogan M, Mollamahmutoglu L (2009) Body mass index is an independent risk factor for the development of endometrial polyps in patients undergoing in vitro fertilization. Fertil Steril 91:1056–1060PubMed

Orvieto R, Bar-Hava I, Dicker D, Bar J, Ben-Rafael Z, Neri A (1999) Endometrial polyps during menopause: characterization and significance. Acta Obstet Gynecol Scand 78:883–886PubMed

Papadia A, Gerbaldo D, Fulcheri E et al (2007) The risk of premalignant and malignant pathology in endometrial polyps: should every polyp be resected? Minerva Ginecol 59:117–124PubMed

Parsons AK, Lense JJ (1993) Sonohysterography for endometrial abnormalities: preliminary results. J Clin Ultrasound 21:87–95PubMed

Pasqualotto EB, Margossian H, Price LL, Bradley LD (2000) Accuracy of preoperative diagnostic tools and outcome of hysteroscopic management of menstrual dysfunction. J Am Assoc Gynecol Laparosc 7:201–209PubMed

Perez-Medina T, Bajo J, Huertas MA, Rubio A (2002) Predicting atypia inside endometrial polyps. J Ultrasound Med 21:125–128PubMed

Perez-Medina T, Bajo-Arenas J, Haya J et al (2003) Tibolone and risk of endometrial polyps: a prospective, comparative study with hormone therapy. Menopause 10:534–537PubMed

Perez-Medina T, Bajo-Arenas J, Salazar F et al (2005) Endometrial polyps and their implication in the pregnancy rates of patients undergoing intrauterine insemination: a prospective, randomized study. Hum Reprod 20:1632–1635PubMed

Perrone G, DeAngelis C, Critelli C, Capri O, Galoppi P, Santoro G et al (2002) Hysteroscopic findings in postmenopausal abnormal uterine bleeding: a comparison between HRT users and non-users. Maturitas 43:251–255PubMed

Peterson WF, Novak ER (1956) Endometrial polyps. Obstet Gynecol 8:40–49PubMed

Preutthipan S, Herabutya Y (2005) Hysteroscopic polypectomy in 240 premenopausal and postmenopausal women. Fertil Steril 83:705–709PubMed

Propst AM, Liberman RF, Harlow BL, Ginsburg ES (2000) Complications of hysteroscopic surgery: predicting patients at risk. Obstet Gynecol 96:517–520PubMed

Raine-Fenning NJ, Campbell BK, Clewes JS, Kendall NR, Johnson IR (2003) The reliability of virtual organ computer-aided analysis (VOCAL) for the semiquantification of ovarian, endometrial and subendometrial perfusion. Ultrasound Obstet Gynecol 22:633–639PubMed

Reslova T, Tosner J, Resl M, Kugler R, Vavrova I (1999) Endometrial polyps. A clinical study of 245 cases. Arch Gynecol Obstet 262:133–139PubMed

Ryan GL, Syrop CH, Van Voorhis BJ (2005) Role, epidemiology, and natural history of benign uterine mass lesions. Clin Obstet Gynecol 48:312–324PubMed

Sant’Ana de Almeida EC, Nogueira AA, Candido dos Reis FJ, Zambelli Ramalho LN, Zucoloto S (2004) Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women. Maturitas 49:229–233PubMed

Savelli L, De IP, Santini D, Rosati F, Ghi T, Pignotti E et al (2003) Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps. Am J Obstet Gynecol 188:927–931PubMed

Schlaen I, Bergeron C, Ferenczy A, Wong P, Naves A, Bertoli R (1988) Endometrial polyps: a study of 204 cases. Surg Pathol 262:133–139

Schwarzler P, Concin H, Bosch H, Berlinger A, Wohlgenannt K, Collins WP et al (1998) An evaluation of sonohysterography and diagnostic hysteroscopy for the assessment of intrauterine pathology. Ultrasound Obstet Gynecol 11:337–342PubMed

Seinera P, Maccario S, Visentin L, DiGregorio A (1988) Hysteroscopy in an IVF-ER program. Clinical experience with 360 infertile patients. Acta Obstet Gynecol Scand 67:135–137PubMed

Shushan A, Revel A, Rojansky N (2004) How often are endometrial polyps malignant? Gynecol Obstet Invest 58:212–215PubMed

Sidhu PS, Allan PL, Cattin F et al (2006) Diagnostic efficacy of SonoVue, a second generation contrast agent, in the assessment of extracranial carotid or peripheral arteries using colour and spectral Doppler ultrasound: a multicentre study. Br J Radiol 79:44–51PubMed

Smith JJ, Schulman H (1985) Current dilatation and curettage practice: a need for revision. Obstet Gynecol 65:516–518PubMed

Stewart CJ, Campbell-Brown M, Critchley HO, Farquharson MA (1999) Endometrial apoptosis in patients with dysfunctional uterine bleeding. Histopathology 34:99–105PubMed

Svirsky R, Smorgick N, Rozowski U et al (2008) Can we rely on blind endometrial biopsy for detection of focal intrauterine pathology? Am J Obstet Gynecol 199:115.e1–3

Syrop CH, Sahakian V (1992) Transvaginal sonographic detection of endometrial polyps with fluid contrast augmentation. Obstet Gynecol 79:1041–1043PubMed

Tanriverdi HA, Barut A, Gun BD, Kaya E (2004) Is pipelle biopsy really adequate for diagnosing endometrial disease? Med Sci Monit 10:CR271–CR274PubMed

Taylor LJ, Jackson TL, Reid JG, Duffy SR (2003) The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki67 in endometrial polyps. Br J Obstet Gynaecol 110:794–798

Testa AC, Ferrandina G, Fruscella E et al (2005) The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases: a preliminary study. J Ultrasound Med 24:1267–1278PubMed

Timmerman D, Verguts J, Konstantinovic ML et al (2003) The pedicle artery sign based on sonography with color Doppler imaging can replace second-stage tests in women with abnormal vaginal bleeding. Ultrasound Obstet Gynecol 22:166–171PubMed

Timmermans A, Gerritse MB, Opmeer BC, Jansen FW, Mol BW, Veersema S (2008) Diagnostic accuracy of endometrial thickness to exclude polyps in women with postmenopausal bleeding. J Clin Ultrasound 36:286–290PubMed

van Bogaert LJ (1988) Clinicopathologic findings in endometrial polyps. Obstet Gynecol 71:771–773PubMed

Vanni R, Dal CP, Marras S, Moerman P, Andria M, Valdes E et al (1993) Endometrial polyp: another benign tumor characterized by 12q13-q15 changes. Cancer Genet Cytogenet 68:32–33PubMed

van Roessel J, Wamsteker K, Exalto N (1987) Sonographic investigation of the uterus during artificial uterine cavity distention. J Clin Ultrasound 15:439–450PubMed

Varasteh NN, Neuwirth RS, Levin B, Keltz MD (1999) Pregnancy rates after hysteroscopic polypectomy and myomectomy in infertile women. Obstet Gynecol 94:168–171PubMed

Vercellini P, Cortesi I, Oldani S, Moschetta M, De GO, Crosignani PG (1997) The role of transvaginal ultrasonography and outpatient diagnostic hysteroscopy in the evaluation of patients with menorrhagia. Hum Reprod 12:1768–1771PubMed

Vilodre LC, Bertat R, Petters R, Reis FM (1997) Cervical polyp as risk factor for hysteroscopically diagnosed endometrial polyps. Gynecol Obstet Invest 44:191–195PubMed

Widrich T, Bradley LD, Mitchinson AR, Collins RL (1996) Comparison of saline infusion sonography with office hysteroscopy for the evaluation of the endometrium. Am J Obstet Gynecol 174:1327–1334PubMed

Word B, Gravelee LC, Wideman GL (1958) The fallacy of simple uterine curettage. Obstet Gynecol 12:642–648PubMed